KORU Medical SystemsKRMD -2.18%76 Current Ratio is 2.33 as of Mar. 2026, which is 55% below its 10-year median of 5.15. GuruFocus rates KRMD with a GF Score™ of 76/100 and a GF Value™ of $4.08 (Fairly Valued). Among 853 Medical Devices & Instruments companies, KORU Medical Systems ranks worse than 54.04% on this metric.
The current ratio is a liquidity ratio that measures a company's ability to pay short-term obligations. It is calculated as a company's Total Current Assets divides by its Total Current Liabilities. KORU Medical Systems's current ratio for the quarter that ended in Mar. 2026 was 2.33.
KORU Medical Systems has a current ratio of 2.33. It generally indicates good short-term financial strength.
The historical rank and industry rank for KORU Medical Systems's Current Ratio or its related term are showing as below:
KRMD'
s Current Ratio Range Over the Past 10 Years
Min: 2.33 Med: 5.15 Max: 11.22
Current: 2.33
During the past 13 years, KORU Medical Systems's highest Current Ratio was 11.22. The lowest was 2.33. And the median was 5.15.
KRMD's Current Ratio is ranked worse than 54.04% of 853
companies
in the Medical Devices & Instruments industry
Industry Median: 2.49
vs KRMD: 2.33
KORU Medical Systems (NAS:KRMD) Current Ratio Explanation
The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.
Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.
The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.
If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.
KORU Medical Systems Current Ratio Related Terms
KORU Medical Systems Current Ratio Historical Data
* Premium members only.
The historical data trend for KORU Medical Systems's Current Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
KRMD vs EMBC, PDEX, SMTI: Current Ratio Comparison
For the Medical Instruments & Supplies subindustry, KORU Medical Systems's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
KORU Medical Systems Current Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, KORU Medical Systems's Current Ratio distribution charts can be found below:
* The bar in red indicates where KORU Medical Systems's Current Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
KORU Medical Systems (KRMD) has a Current Ratio of 2.33 as of Mar. 2026. This is 55% below median its historical median of 5.15. Over the past decade, KORU Medical Systems' Current Ratio has ranged from 2.33 to 11.22. According to the industry distribution chart, KORU Medical Systems ranks #461 out of 853 companies in the Medical Devices & Instruments industry, placing it in the top 54%.
Is KORU Medical Systems' Current Ratio too high?
KORU Medical Systems' current Current Ratio of 2.33 is 55% below median its 10-year median of 5.15. Over the past 10 years, this metric has ranged from a low of 2.33 to a high of 11.22. The Medical Devices & Instruments industry median Current Ratio is 2.49. KORU Medical Systems' value of 2.33 is 6.4% below this industry median. Based on the distribution chart, KORU Medical Systems ranks #461 out of 853 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, KORU Medical Systems has a GF Score™ of 76/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does KORU Medical Systems' Current Ratio compare to EMBC and PDEX?
According to the Medical Devices & Instruments industry distribution chart, KORU Medical Systems ranks #461 out of 853 companies for Current Ratio. This places KORU Medical Systems in the lower half of its industry. The industry median Current Ratio is 2.49. KORU Medical Systems' value of 2.33 is 6.4% below this benchmark. Historically, KORU Medical Systems' own Current Ratio has ranged from 2.33 to 11.22 over the past decade. While the company's 10-year median is 5.15 vs. the industry median of 2.49, KORU Medical Systems has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Ratio for a Medical Devices & Instruments company?
The median Current Ratio among Medical Devices & Instruments companies is 2.49, based on 853 companies in the industry. Companies in the top quartile (top 25%) have a Current Ratio significantly above this median, while those in the bottom quartile fall well below. However, Current Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. KORU Medical Systems's current Current Ratio of 2.33 is 6.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Ratio mean?
A high Current Ratio can signal that a stock is expensive relative to its fundamentals. For the Medical Devices & Instruments industry, the median Current Ratio is 2.49 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. KORU Medical Systems's current Current Ratio is 2.33, which is 55% below median its own 10-year median of 5.15. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is KORU Medical Systems stock overvalued right now?
Based on GuruFocus' analysis, KORU Medical Systems (KRMD) is currently considered Fairly Valued. The stock's GF Value™ is $4.08, compared to a current price of $4.49 — trading 10% above its estimated fair value. The current Current Ratio is 2.33, which is 55% below median its 10-year median of 5.15 and 6.4% below the Medical Devices & Instruments industry median of 2.49. KORU Medical Systems' overall GF Score™ is 76/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Ratio calculated?
Current Ratio is calculated from a company's financial statements. For KORU Medical Systems (KRMD), the current Current Ratio is 2.33 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is KORU Medical Systems (KRMD) Overvalued in 2026?
Based on GuruFocus' analysis, KORU Medical Systems stock appears to be overvalued.
The current stock price of $4.49 is trading 10% above its estimated GF Value™ of $4.08.
GuruFocus considers KORU Medical Systems to be Fairly Valued.
Key valuation signals for KRMD:
Current Ratio: 2.33 (55% below median its 10-year median of 5.15)
GF Value™: $4.08 vs. price of $4.49 (10% above fair value)
Industry Position: 6.4% below the Medical Devices & Instruments median (#461 of 853)
No single metric tells the full story. See the KRMD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
KORU Medical Systems Inc develops, manufactures, and commercializes large volume subcutaneous infusion solutions for the subcutaneous drug delivery market. Its product portfolio focuses on mechanical infusion devices, including the FREEDOM60 and FreedomEdge syringe drivers, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing. The company operates as one segment. Its revenue streams are: Domestic Core, International Core and Pharma services and clinical trials. The majority of the company's revenue is derived from the Domestic Core business, which consists of sales of its syringe drivers, tubing and needles. Geographically, its revenues are predominantly derived from the United States.
76GF Score
Get the complete analysis for KRMD
Current Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
KRMD has been successfully added to your 
